ENOX2: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
imported>Citation bot
m (Alter: issue. Add: year. Removed parameters. Formatted dashes. | You can use this bot yourself. Report bugs here. | User-activated.)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''ENOX2''' is a [[gene]] located on the long arm of the [[X chromosome]] in [[human]]s.<ref name=":0">{{Cite web|url=https://www.ncbi.nlm.nih.gov/gene/10495|title=ENOX2 ecto-NOX disulfide-thiol exchanger 2 [ Homo sapiens (human) ]|last=|first=|date=|website=NCBI|publisher=|access-date=2016-10-16}}</ref> The gene encodes the [[protein]] '''Ecto-NOX disulfide-thiol exchanger 2''', a member of the NOX family of [[NADPH oxidase]]s.<ref name="pmid8150545">{{cite journal | vauthors = Chang K, Pastan I | title = Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line | journal = Int J Cancer | volume = 57 | issue = 1 | pages = 90–7 |date=May 1994 | pmid = 8150545 | pmc =  | doi =10.1002/ijc.2910570117  }}</ref><ref name="pmid11888291">{{cite journal | vauthors = Chueh PJ, Kim C, Cho N, Morre DM, Morre DJ | title = Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface | journal = Biochemistry | volume = 41 | issue = 11 | pages = 3732–41 |date=Mar 2002 | pmid = 11888291 | pmc =  | doi =10.1021/bi012041t  }}</ref><ref name=":1">{{Cite journal|last=Morré|first=D. James|last2=Morré|first2=Dorothy M.|date=2003-08-01|title=Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases|journal=Free Radical Research|volume=37|issue=8|pages=795–808|issn=1071-5762|pmid=14567438|doi=10.1080/1071576031000083107}}</ref>
| update_page = yes
 
| require_manual_inspection = no
Ecto-NOX disulfide-thiol exchanger 2 is a growth-related cell surface protein. It was identified because it reacts with the [[monoclonal antibody]] K1 in cells, such as the ovarian carcinoma line [[OVCAR-3]], also expressing the CAKI surface [[glycoprotein]].<ref name="pmid8150545" /> The encoded protein has two [[Enzyme|enzymatic activities]]: [[catalysis]] of [[hydroquinone]] or [[Nicotinamide adenine dinucleotide|NADH]] [[Redox|oxidation]], and [[Disulfide#Occurrence in proteins|protein disulfide interchange]]. The two activities alternate with a period length of about 24 minutes. The encoded protein also displays [[prion]]-like properties. Two transcript variants encoding different [[Protein isoform|isoforms]] have been found for this gene.<ref name="entrez2">{{cite web|url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10495|title=Entrez Gene: COVA1 cytosolic ovarian carcinoma antigen 1|accessdate=}}</ref>
| update_protein_box = yes
 
| update_summary = yes
== Gene Location ==
| update_citations = yes
The human ENOX2 gene is located on the long (q) arm of the X chromosome in humans, at region 2 band 6 sub band 1, from base pair 130,622,330 to 130,903,317 (build GRCh38.p7) ([https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&acc=10495 map]). The gene is conserved in chimpanzee, Rhesus monkey, dog, mouse, rat, chicken, and zebrafish.<ref name=":0" />
}}
 
== Function ==
ENOX2 and related NOX proteins exhibit two distinct oscillating functions: the oxidation of NADH to [[NAD+]] and a [[Protein disulfide-isomerase|protein disulfide isomerase]]-like activity, unprecedented in the biochemical literature.<ref name=":1" /><ref name=":2">{{Cite journal|last=Morré|first=D. James|last2=Morré|first2=Dorothy M.|date=1998-11-01|title=NADH oxidase activity of soybean plasma membranes oscillates with a temperature compensated period of 24 min|journal=The Plant Journal|language=en|volume=16|issue=3|pages=277–284|doi=10.1046/j.1365-313x.1998.00293.x|issn=1365-313X}}</ref><ref>{{Cite journal|last=Morré|first=D. J.|last2=Chueh|first2=P. J.|last3=Lawler|first3=J.|last4=Morré|first4=D. M.|date=1998-10-01|title=The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity|pmid=9932650|journal=Journal of Bioenergetics and Biomembranes|volume=30|issue=5|pages=477–487|issn=0145-479X|doi=10.1023/A:1020594214379}}</ref><ref name=":3">{{Cite journal|last=Sun|first=Peichuan|last2=Morré|first2=D. James|last3=Morré|first3=Dorothy M.|date=2000-10-20|title=Periodic NADH oxidase activity associated with an endoplasmic reticulum fraction from pig liver. Response to micromolar concentrations of retinol|url=http://www.sciencedirect.com/science/article/pii/S0167488900000793|journal=Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|volume=1498|issue=1|pages=52–63|doi=10.1016/S0167-4889(00)00079-3}}</ref> Regarding NADH oxidation, the protein has a [[Enzyme assay#Specific activity|specific activity]] of 10-20µmol/min/mg of protein with a [[turnover number]] of 200-500.<ref>{{Cite journal|last=Yantiri|first=F.|last2=Morré|first2=D. J.|date=2001-07-15|title=Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface|pmid=11437345|journal=Archives of Biochemistry and Biophysics|volume=391|issue=2|pages=149–159|doi=10.1006/abbi.2001.2404|issn=0003-9861}}</ref><ref>{{Cite journal|last=del Castillo-Olivares|first=A.|last2=Yantiri|first2=F.|last3=Chueh|first3=P. J.|last4=Wang|first4=S.|last5=Sweeting|first5=M.|last6=Sedlak|first6=D.|last7=Morré|first7=D. M.|last8=Burgess|first8=J.|last9=Morré|first9=D. J.|date=1998-10-01|title=A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells|pmid=9750173|journal=Archives of Biochemistry and Biophysics|volume=358|issue=1|pages=125–140|doi=10.1006/abbi.1998.0823|issn=0003-9861}}</ref> The oscillations are independent of temperature, with a period of 24 minutes, completing 60 cycles in a 24-hour day.<ref name=":2" /><ref name=":3" /> The period of oscillation changes to 22 and 26 minutes in the cancer related (tNOX) and age-related (arNOX) forms respectively.<ref name=":1" /> This regular oscillation is attributed to the maintenance of biological clock<ref name=":1" /><ref>{{Cite journal|last=Morré|first=D. James|last2=Chueh|first2=Pin-Ju|last3=Pletcher|first3=Jake|last4=Tang|first4=Xiaoyu|last5=Wu|first5=Lian-Ying|last6=Morré|first6=Dorothy M.|date=2002-10-08|title=Biochemical basis for the biological clock|pmid=12356293|journal=Biochemistry|volume=41|issue=40|pages=11941–11945|issn=0006-2960|doi=10.1021/bi020392h}}</ref>
 
=== Interactions ===
NADH activity of ENOX2 has been shown to be stimulated by various [[hormone]]s and [[growth factor]]s, including [[insulin]], [[Epidermal growth factor|EGF]], [[transferrin]], [[lactoferrin]], [[vasopressin]] and [[glucagon]].<ref name=":4">{{Cite journal|last=Bruno|first=M|last2=Brightman|first2=A O|last3=Lawrence|first3=J|last4=Werderitsh|first4=D|last5=Morré|first5=D M|last6=Morre|first6=D J|date=1992-06-15|title=Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes.|pmc=1132580|journal=Biochemical Journal|volume=284|issue=Pt 3|pages=625–628|issn=0264-6021|doi=10.1042/bj2840625|pmid=1622384}}</ref> This stimulation is not seen in protein samples recovered from cancer cells, suggesting the regular NADH oxidase activity of ENOX2 is decoupled in [[cancer]].<ref name=":4" /> ENOX2 also has a number of [[Protein–protein interaction|protein-protein interactions]], with ENOX1 and [[SOX2]], among others.<ref>{{Cite web|url=https://thebiogrid.org/115758|title=ENOX2 (RP5-875H3.1) Result Summary {{!}} BioGRID|last=Lab|first=Mike Tyers|website=thebiogrid.org|access-date=2016-10-16}}</ref>
 
=== Cell Growth ===
Numerous studies in the 1990s correlated NADH oxidase activity with cell growth.<ref name=":1" /> Conditions which stimulated cell growth also stimulated NADH oxidase activity and conditions that inhibited cell growth inhibited NADH oxidase activity. Further experimental evidence showed that the rate of cell enlargement oscillates within the 24 minute oscillation of ENOX function.<ref>{{Cite journal|last=Wang|first=S.|last2=Pogue|first2=R.|last3=Morré|first3=D. M.|last4=Morré|first4=D. J.|date=2001-06-20|title=NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms|pmid=11420117|journal=Biochimica et Biophysica Acta|volume=1539|issue=3|pages=192–204|issn=0006-3002|doi=10.1016/s0167-4889(01)00107-0}}</ref> Maximum cell growth rates correspond to the portion of the ENOX cycle involved in protein dulsulfide bridge formation.<ref>{{Cite journal|last=Morré|first=D. James|last2=Pogue|first2=Rhea|last3=Morré|first3=Dorothy M.|title=Soybean cell enlargement oscillates with a temperature-compensated period length of CA. 24 min|journal=In Vitro Cellular & Developmental Biology - Plant|language=en|volume=37|issue=1|pages=19–23|doi=10.1007/s11627-001-0004-3|issn=1054-5476|year=2001}}</ref> Theories suggest that ENOX is responsible for the breakup and formation of disulfide bonds in [[Cell membrane|membrane]] proteins, thus maximum cell growth coincides with maximum protein disulfide interchange activity.<ref name=":1" />


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== Role In Disease ==
{{GNF_Protein_box
| image =
| image_source =
| PDB =  
| Name = Cytosolic ovarian carcinoma antigen 1
| HGNCid = 2259
| Symbol = COVA1
| AltSymbols =; APK1; tNOX
| OMIM = 300282
| ECnumber = 
| Homologene = 17120
| MGIid = 2384799
| GeneAtlas_image1 = PBB_GE_COVA1_32042_at_tn.png
| GeneAtlas_image2 = PBB_GE_COVA1_204643_s_at_tn.png
| GeneAtlas_image3 = PBB_GE_COVA1_204644_at_tn.png
| Function = {{GNF_GO|id=GO:0000166 |text = nucleotide binding}} {{GNF_GO|id=GO:0003676 |text = nucleic acid binding}} {{GNF_GO|id=GO:0005507 |text = copper ion binding}} {{GNF_GO|id=GO:0015035 |text = protein disulfide oxidoreductase activity}} {{GNF_GO|id=GO:0016491 |text = oxidoreductase activity}}
| Component = {{GNF_GO|id=GO:0005829 |text = cytosol}} {{GNF_GO|id=GO:0009897 |text = external side of plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}}
| Process = {{GNF_GO|id=GO:0001558 |text = regulation of cell growth}} {{GNF_GO|id=GO:0006118 |text = electron transport}} {{GNF_GO|id=GO:0006810 |text = transport}} {{GNF_GO|id=GO:0007624 |text = ultradian rhythm}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 10495
    | Hs_Ensembl = ENSG00000165675
    | Hs_RefseqProtein = NP_006366
    | Hs_RefseqmRNA = NM_006375
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = X
    | Hs_GenLoc_start = 129585031
    | Hs_GenLoc_end = 129864889
    | Hs_Uniprot = Q16206
    | Mm_EntrezGene = 209224
    | Mm_Ensembl = ENSMUSG00000031109
    | Mm_RefseqmRNA = NM_145951
    | Mm_RefseqProtein = NP_666063
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = X
    | Mm_GenLoc_start = 45255149
    | Mm_GenLoc_end = 45532869
    | Mm_Uniprot = Q3UT06
  }}
}}
'''Cytosolic ovarian carcinoma antigen 1''', also known as '''COVA1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: COVA1 cytosolic ovarian carcinoma antigen 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10495| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
=== Cancer ===
{{PBB_Summary
The cancer associated, drug responsive variant of ENOX, tNOX, arises as a [[Alternative splicing|splice variant]] and is found on the cell surface of human cancers.<ref name=":1" /><ref>{{Cite journal|title=Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients|journal=Cancer Immunol Immunother|volume=51}}</ref> tNOX exhibits a periodicity of 22 minutes, compared to the native 24 minutes and can be inhibited by a number of anticancer drugs, without affecting the native ENOX.<ref name=":1" /> These properties of tNOX are being used to develop early detection and intervention mechanisms for human cancers.<ref>{{Cite book|url=http://www.intechopen.com/books/cancer-prevention-from-mechanisms-to-translational-benefits/early-detection-an-opportunity-for-cancer-prevention-through-early-intervention|title=Early Detection: An Opportunity for Cancer Prevention Through Early Intervention|last=James|first=D.|last2=M.|first2=Dorothy|date=2012-04-20|publisher=InTech|isbn=9789535105473|language=en|doi=10.5772/32415}}</ref>
| section_title =  
| summary_text = The protein encoded by this gene is a growth-related cell surface protein. It was identifed because it reacts with the monoclonal antibody KI in cells, such as the ovarian carcinoma line OVCAR-3, also expressing the CAKI surface glycoprotein. The encoded protein has two enzymatic activities: catalysis of hydroquinone or NADH oxidation, and protein disulfide interchange. The two activities alternate with a period length of about 24 minutes. The encoded protein also displays prion-like properties. Two transcript variants encoding different isoforms have been found for this gene.<ref name="entrez">{{cite web | title = Entrez Gene: COVA1 cytosolic ovarian carcinoma antigen 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10495| accessdate = }}</ref>
}}


==References==
==References==
{{reflist|2}}
{{reflist}}
 
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal  | author=Tarasoutchi F, Grinberg M, de Figueiredo Neto JA, ''et al.'' |title=[Mitral valve aneurysm associated with mitral insufficiency in absence of aortic insufficiency] |journal=Arq. Bras. Cardiol. |volume=56 |issue= 3 |pages= 231-4 |year= 1991 |pmid= 1888291 |doi= }}
*{{cite journal  | vauthors=Tarasoutchi F, Grinberg M, de Figueiredo Neto JA |title=[Mitral valve aneurysm associated with mitral insufficiency in absence of aortic insufficiency] |journal=Arq. Bras. Cardiol. |volume=56 |issue= 3 |pages= 231–4 |year= 1991 |pmid= 1888291 |doi=  |display-authors=etal}}
*{{cite journal | author=Chang K, Pastan I |title=Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. |journal=Int. J. Cancer |volume=57 |issue= 1 |pages= 90-7 |year= 1994 |pmid= 8150545 |doi=  }}
*{{cite journal  | vauthors=Dai S, Morré DJ, Geilen CC |title=Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids. |journal=Mol. Cell. Biochem. |volume=166 |issue= 1–2 |pages= 101–9 |year= 1997 |pmid= 9046026 |doi=10.1023/A:1006866726050 |display-authors=etal}}
*{{cite journal  | author=Dai S, Morré DJ, Geilen CC, ''et al.'' |title=Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids. |journal=Mol. Cell. Biochem. |volume=166 |issue= 1-2 |pages= 101-9 |year= 1997 |pmid= 9046026 |doi=  }}
*{{cite journal  | vauthors=Morré DJ, Chueh PJ, Lawler J, Morré DM |title=The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity. |journal=J. Bioenerg. Biomembr. |volume=30 |issue= 5 |pages= 477–87 |year= 1999 |pmid= 9932650 |doi=10.1023/A:1020594214379 }}
*{{cite journal  | author=Morré DJ, Chueh PJ, Lawler J, Morré DM |title=The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity. |journal=J. Bioenerg. Biomembr. |volume=30 |issue= 5 |pages= 477-87 |year= 1999 |pmid= 9932650 |doi=  }}
*{{cite journal  | vauthors=Kishi T, Morré DM, Morré DJ |title=The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. |journal=Biochim. Biophys. Acta |volume=1412 |issue= 1 |pages= 66–77 |year= 1999 |pmid= 10354495 |doi=10.1016/S0005-2728(99)00049-3 }}
*{{cite journal  | author=Kishi T, Morré DM, Morré DJ |title=The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. |journal=Biochim. Biophys. Acta |volume=1412 |issue= 1 |pages= 66-77 |year= 1999 |pmid= 10354495 |doi=  }}
*{{cite journal  | vauthors=Kelker M, Kim C, Chueh PJ |title=Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion. |journal=Biochemistry |volume=40 |issue= 25 |pages= 7351–4 |year= 2001 |pmid= 11412089 |doi=10.1021/bi010596i |display-authors=etal}}
*{{cite journal  | author=Kelker M, Kim C, Chueh PJ, ''et al.'' |title=Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion. |journal=Biochemistry |volume=40 |issue= 25 |pages= 7351-4 |year= 2001 |pmid= 11412089 |doi=  }}
*{{cite journal  | vauthors=Yantiri F, Morré DJ |title=Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface. |journal=Arch. Biochem. Biophys. |volume=391 |issue= 2 |pages= 149–59 |year= 2001 |pmid= 11437345 |doi= 10.1006/abbi.2001.2404 }}
*{{cite journal  | author=Yantiri F, Morré DJ |title=Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface. |journal=Arch. Biochem. Biophys. |volume=391 |issue= 2 |pages= 149-59 |year= 2001 |pmid= 11437345 |doi= 10.1006/abbi.2001.2404 }}
*{{cite journal  | vauthors=Morré DJ, Sedlak D, Tang X |title=Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs. |journal=Arch. Biochem. Biophys. |volume=392 |issue= 2 |pages= 251–6 |year= 2001 |pmid= 11488599 |doi= 10.1006/abbi.2001.2436 |display-authors=etal}}
*{{cite journal  | author=Morré DJ, Sedlak D, Tang X, ''et al.'' |title=Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs. |journal=Arch. Biochem. Biophys. |volume=392 |issue= 2 |pages= 251-6 |year= 2001 |pmid= 11488599 |doi= 10.1006/abbi.2001.2436 }}
*{{cite journal  | vauthors=Chueh PJ, Morré DM, Morré DJ |title=A site-directed mutagenesis analysis of tNOX functional domains. |journal=Biochim. Biophys. Acta |volume=1594 |issue= 1 |pages= 74–83 |year= 2002 |pmid= 11825610 |doi=  10.1016/s0167-4838(01)00286-2}}
*{{cite journal  | author=Chueh PJ, Morré DM, Morré DJ |title=A site-directed mutagenesis analysis of tNOX functional domains. |journal=Biochim. Biophys. Acta |volume=1594 |issue= 1 |pages= 74-83 |year= 2002 |pmid= 11825610 |doi=  }}
*{{cite journal  | vauthors=Cho N, Chueh PJ, Kim C |title=Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. |journal=Cancer Immunol. Immunother. |volume=51 |issue= 3 |pages= 121–9 |year= 2002 |pmid= 11941450 |doi= 10.1007/s00262-001-0262-2 |display-authors=etal}}
*{{cite journal  | author=Chueh PJ, Kim C, Cho N, ''et al.'' |title=Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. |journal=Biochemistry |volume=41 |issue= 11 |pages= 3732-41 |year= 2002 |pmid= 11888291 |doi=  }}
*{{cite journal  | vauthors=Morré DJ, Chueh PJ, Pletcher J |title=Biochemical basis for the biological clock. |journal=Biochemistry |volume=41 |issue= 40 |pages= 11941–5 |year= 2002 |pmid= 12356293 |doi=10.1021/bi020392h |display-authors=etal}}
*{{cite journal  | author=Cho N, Chueh PJ, Kim C, ''et al.'' |title=Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. |journal=Cancer Immunol. Immunother. |volume=51 |issue= 3 |pages= 121-9 |year= 2002 |pmid= 11941450 |doi= 10.1007/s00262-001-0262-2 }}
*{{cite journal  | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}}
*{{cite journal  | author=Morré DJ, Chueh PJ, Pletcher J, ''et al.'' |title=Biochemical basis for the biological clock. |journal=Biochemistry |volume=41 |issue= 40 |pages= 11941-5 |year= 2002 |pmid= 12356293 |doi=  }}
*{{cite journal  | vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal}}
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}}
*{{cite journal  | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
*{{cite journal  | vauthors=Chueh PJ, Wu LY, Morré DM, Morré DJ |title=tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. |journal=BioFactors |volume=20 |issue= 4 |pages= 235–49 |year= 2005 |pmid= 15706060 |doi=  }}
*{{cite journal  | author=Gerhard DS, Wagner L, Feingold EA, ''et al.'' |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121-7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 }}
*{{cite journal  | vauthors=Ross MT, Grafham DV, Coffey AJ |title=The DNA sequence of the human X chromosome. |journal=Nature |volume=434 |issue= 7031 |pages= 325–37 |year= 2005 |pmid= 15772651 |doi= 10.1038/nature03440 | pmc=2665286 |display-authors=etal}}
*{{cite journal  | author=Chueh PJ, Wu LY, Morré DM, Morré DJ |title=tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. |journal=Biofactors |volume=20 |issue= 4 |pages= 235-49 |year= 2005 |pmid= 15706060 |doi=  }}
*{{cite journal  | vauthors=Rual JF, Venkatesan K, Hao T |title=Towards a proteome-scale map of the human protein-protein interaction network. |journal=Nature |volume=437 |issue= 7062 |pages= 1173–8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209 |display-authors=etal}}
*{{cite journal  | author=Ross MT, Grafham DV, Coffey AJ, ''et al.'' |title=The DNA sequence of the human X chromosome. |journal=Nature |volume=434 |issue= 7031 |pages= 325-37 |year= 2005 |pmid= 15772651 |doi= 10.1038/nature03440 }}
*{{cite journal  | author=Rual JF, Venkatesan K, Hao T, ''et al.'' |title=Towards a proteome-scale map of the human protein-protein interaction network. |journal=Nature |volume=437 |issue= 7062 |pages= 1173-8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209 }}
}}
}}
{{refend}}
{{refend}}


{{protein-stub}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{WikiDoc Sources}}
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}

Latest revision as of 11:09, 14 January 2019

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

ENOX2 is a gene located on the long arm of the X chromosome in humans.[1] The gene encodes the protein Ecto-NOX disulfide-thiol exchanger 2, a member of the NOX family of NADPH oxidases.[2][3][4]

Ecto-NOX disulfide-thiol exchanger 2 is a growth-related cell surface protein. It was identified because it reacts with the monoclonal antibody K1 in cells, such as the ovarian carcinoma line OVCAR-3, also expressing the CAKI surface glycoprotein.[2] The encoded protein has two enzymatic activities: catalysis of hydroquinone or NADH oxidation, and protein disulfide interchange. The two activities alternate with a period length of about 24 minutes. The encoded protein also displays prion-like properties. Two transcript variants encoding different isoforms have been found for this gene.[5]

Gene Location

The human ENOX2 gene is located on the long (q) arm of the X chromosome in humans, at region 2 band 6 sub band 1, from base pair 130,622,330 to 130,903,317 (build GRCh38.p7) (map). The gene is conserved in chimpanzee, Rhesus monkey, dog, mouse, rat, chicken, and zebrafish.[1]

Function

ENOX2 and related NOX proteins exhibit two distinct oscillating functions: the oxidation of NADH to NAD+ and a protein disulfide isomerase-like activity, unprecedented in the biochemical literature.[4][6][7][8] Regarding NADH oxidation, the protein has a specific activity of 10-20µmol/min/mg of protein with a turnover number of 200-500.[9][10] The oscillations are independent of temperature, with a period of 24 minutes, completing 60 cycles in a 24-hour day.[6][8] The period of oscillation changes to 22 and 26 minutes in the cancer related (tNOX) and age-related (arNOX) forms respectively.[4] This regular oscillation is attributed to the maintenance of biological clock[4][11]

Interactions

NADH activity of ENOX2 has been shown to be stimulated by various hormones and growth factors, including insulin, EGF, transferrin, lactoferrin, vasopressin and glucagon.[12] This stimulation is not seen in protein samples recovered from cancer cells, suggesting the regular NADH oxidase activity of ENOX2 is decoupled in cancer.[12] ENOX2 also has a number of protein-protein interactions, with ENOX1 and SOX2, among others.[13]

Cell Growth

Numerous studies in the 1990s correlated NADH oxidase activity with cell growth.[4] Conditions which stimulated cell growth also stimulated NADH oxidase activity and conditions that inhibited cell growth inhibited NADH oxidase activity. Further experimental evidence showed that the rate of cell enlargement oscillates within the 24 minute oscillation of ENOX function.[14] Maximum cell growth rates correspond to the portion of the ENOX cycle involved in protein dulsulfide bridge formation.[15] Theories suggest that ENOX is responsible for the breakup and formation of disulfide bonds in membrane proteins, thus maximum cell growth coincides with maximum protein disulfide interchange activity.[4]

Role In Disease

Cancer

The cancer associated, drug responsive variant of ENOX, tNOX, arises as a splice variant and is found on the cell surface of human cancers.[4][16] tNOX exhibits a periodicity of 22 minutes, compared to the native 24 minutes and can be inhibited by a number of anticancer drugs, without affecting the native ENOX.[4] These properties of tNOX are being used to develop early detection and intervention mechanisms for human cancers.[17]

References

  1. ↑ 1.0 1.1 "ENOX2 ecto-NOX disulfide-thiol exchanger 2 [ Homo sapiens (human) ]". NCBI. Retrieved 2016-10-16.
  2. ↑ 2.0 2.1 Chang K, Pastan I (May 1994). "Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line". Int J Cancer. 57 (1): 90–7. doi:10.1002/ijc.2910570117. PMID 8150545.
  3. ↑ Chueh PJ, Kim C, Cho N, Morre DM, Morre DJ (Mar 2002). "Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface". Biochemistry. 41 (11): 3732–41. doi:10.1021/bi012041t. PMID 11888291.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 Morré, D. James; Morré, Dorothy M. (2003-08-01). "Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases". Free Radical Research. 37 (8): 795–808. doi:10.1080/1071576031000083107. ISSN 1071-5762. PMID 14567438.
  5. ↑ "Entrez Gene: COVA1 cytosolic ovarian carcinoma antigen 1".
  6. ↑ 6.0 6.1 Morré, D. James; Morré, Dorothy M. (1998-11-01). "NADH oxidase activity of soybean plasma membranes oscillates with a temperature compensated period of 24 min". The Plant Journal. 16 (3): 277–284. doi:10.1046/j.1365-313x.1998.00293.x. ISSN 1365-313X.
  7. ↑ Morré, D. J.; Chueh, P. J.; Lawler, J.; Morré, D. M. (1998-10-01). "The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity". Journal of Bioenergetics and Biomembranes. 30 (5): 477–487. doi:10.1023/A:1020594214379. ISSN 0145-479X. PMID 9932650.
  8. ↑ 8.0 8.1 Sun, Peichuan; Morré, D. James; Morré, Dorothy M. (2000-10-20). "Periodic NADH oxidase activity associated with an endoplasmic reticulum fraction from pig liver. Response to micromolar concentrations of retinol". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1498 (1): 52–63. doi:10.1016/S0167-4889(00)00079-3.
  9. ↑ Yantiri, F.; Morré, D. J. (2001-07-15). "Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface". Archives of Biochemistry and Biophysics. 391 (2): 149–159. doi:10.1006/abbi.2001.2404. ISSN 0003-9861. PMID 11437345.
  10. ↑ del Castillo-Olivares, A.; Yantiri, F.; Chueh, P. J.; Wang, S.; Sweeting, M.; Sedlak, D.; Morré, D. M.; Burgess, J.; Morré, D. J. (1998-10-01). "A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells". Archives of Biochemistry and Biophysics. 358 (1): 125–140. doi:10.1006/abbi.1998.0823. ISSN 0003-9861. PMID 9750173.
  11. ↑ Morré, D. James; Chueh, Pin-Ju; Pletcher, Jake; Tang, Xiaoyu; Wu, Lian-Ying; Morré, Dorothy M. (2002-10-08). "Biochemical basis for the biological clock". Biochemistry. 41 (40): 11941–11945. doi:10.1021/bi020392h. ISSN 0006-2960. PMID 12356293.
  12. ↑ 12.0 12.1 Bruno, M; Brightman, A O; Lawrence, J; Werderitsh, D; Morré, D M; Morre, D J (1992-06-15). "Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes". Biochemical Journal. 284 (Pt 3): 625–628. doi:10.1042/bj2840625. ISSN 0264-6021. PMC 1132580. PMID 1622384.
  13. ↑ Lab, Mike Tyers. "ENOX2 (RP5-875H3.1) Result Summary | BioGRID". thebiogrid.org. Retrieved 2016-10-16.
  14. ↑ Wang, S.; Pogue, R.; Morré, D. M.; Morré, D. J. (2001-06-20). "NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms". Biochimica et Biophysica Acta. 1539 (3): 192–204. doi:10.1016/s0167-4889(01)00107-0. ISSN 0006-3002. PMID 11420117.
  15. ↑ Morré, D. James; Pogue, Rhea; Morré, Dorothy M. (2001). "Soybean cell enlargement oscillates with a temperature-compensated period length of CA. 24 min". In Vitro Cellular & Developmental Biology - Plant. 37 (1): 19–23. doi:10.1007/s11627-001-0004-3. ISSN 1054-5476.
  16. ↑ "Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients". Cancer Immunol Immunother. 51.
  17. ↑ James, D.; M., Dorothy (2012-04-20). Early Detection: An Opportunity for Cancer Prevention Through Early Intervention. InTech. doi:10.5772/32415. ISBN 9789535105473.

Further reading


Retrieved from "https://www.wikidoc.org/index.php?title=ENOX2&oldid=1542064"